siRNA treatment decreases triglycerides in people along with rare disorder

.RESEARCH STUDY HIGHLIGHT.19 September 2024.

Plozasiran lowered triglyceride amounts by 80% and lowered the danger of pancreatitis in individuals with persistent chylomicronemia, with or even without a genetic diagnosis.